ClinicalTrials.Veeva

Find clinical trials for Diabetes in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Macular Edema
Obesity

Diabetes trials near London, England, GBR:

AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce (ADOPTION)

AZD1656 in Transplantation with Diabetes tO PromoTe Immune TOleraNce: a single site, placebo-controlled, double-blind randomised clinical tr...

Active, not recruiting
Type 2 Diabetes
Diabetes Mellitus, Type 2
Drug: AZD1656
Drug: Placebo

Phase 2

Queen Mary University of London

London, United Kingdom

months (+ 14 days) to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies i...

Enrolling
Diabetes Mellitus, Type 1
Dietary Supplement: B. infantis
Dietary Supplement: Placebo
Helmholtz Zentrum München

Cambridge, United Kingdom and 7 other locations

A trial of patients with type 2 diabetes mellitus to evaluate the comparative effectiveness between dapagliflozin and Standard of Care (SOC)...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Dapagliflozin
Drug: Standard of Care

Phase 4

University of Liverpool

London, United Kingdom and 128 other locations

The IMPACT study is a study to test a new experimental drug, IMCY-0098, for the treatment of type 1 diabetes (T1D).In most people with type ...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Placebo
Drug: IMCY-0098 1350 μg

Phase 2

Imcyse

London, United Kingdom and 28 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Active, not recruiting
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)

Phase 3

Prokidney

London, United Kingdom and 45 other locations

Locations recently updated

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of ...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health Inc.

London, England, United Kingdom and 60 other locations

The main purpose of this study is to learn more about the safety and efficacy of investigational tirzepatide doses in participants with Type 2 diabetes...

Enrolling
Type 2 Diabetes
Obesity
Drug: Tirzepatide
Drug: Placebo

Phase 2

Lilly
Lilly

London, Hammersmith And Fulham, United Kingdom and 58 other locations

+ 12-week 800kcal/day low-energy diet, delivered remotely) is more likely to lead to weight loss and remission in adults with type 2 diabetes...

Invitation-only
Diabetes Mellitus, Type 2
Other: Standard of care
Combination Product: Digital therapeutic and intensive lifestyle programme
Habitual Health

London, United Kingdom

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

London, United Kingdom and 89 other locations

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Enrolling
Type 2 Diabetes
Drug: Placebo
Drug: Retatrutide

Phase 3

Lilly
Lilly

Stevenage, Hertfordshire, United Kingdom and 38 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems